Results 151 to 160 of about 288,388 (279)

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

B cell receptor signaling in autoimmune rheumatic diseases: regulatory mechanisms and therapeutic targeting. [PDF]

Front Immunol
Zhu Y, Gao L, Han Y, Liu F, Xie X, Dai X, Wang Y, Guo Y, Luo C, Chen Y, Huang P, Du Z.   +11 more
europepmc   +1 more source

Novel Bispecific Engagers Targeting the CεmX Domain of mIgE‐Expressing Cells

Allergy, EarlyView.
We developed bispecific TCE & NKCE targeting the CεmX domain of mIgE to eliminate IgE‐producing cells. Both constructs demonstrated potent, specific, dose‐dependent cytotoxicity and selective immune activation in vitro. These results highlight their promise as off‐the‐shelf, potentially curative therapeutics for IgE‐associated allergic diseases ...
Constantin Möller, Julia Hambach, Alessa Zoe Schaffrath, Thomas Eden, Sophia Cichutek, Anna Josephine Gebhardt, Natalie Tode, Ronald Maitschke‐Rajasekharan, Philipp Lewe, Sharon Qi, Susanne Witt, Marie Eggers, Nicola M. Tomas, Friedrich Haag, Friedrich Koch‐Nolte, Boris Fehse, Kristoffer Riecken   +16 more
wiley   +1 more source

School achievement in the Brazilian rural Amazon: An analysis of the interaction among motor, cognitive and environmental factors

British Journal of Developmental Psychology, EarlyView.
Abstract A cross‐sectional study of 106 students (7–12 years) from a rural school in the Brazilian Amazon investigated the interaction among motor, cognitive and environmental factors on school achievement using network analysis. Students with good school performance were significantly older and showed superior global physical fitness, motor ...
Douglas Vieira, Cinthia Rodrigues Barros, Mabliny Thuany, Thayse Natacha Gomes   +3 more
wiley   +1 more source

Large-scale paired chain BCR analysis reveals antibody clonal family inference bias and enhances resolution with machine learning. [PDF]

PLoS Comput Biol
Wang H, Wang K, Xu Q, Cai L, Huang C, Chen L, Zang Y, Hu X, Zhang J.   +8 more
europepmc   +1 more source

Optical genome mapping detects cryptic high‐risk and targetable abnormalities in adult AML

British Journal of Haematology, EarlyView.
Summary Acute myeloid leukaemia (AML) risk stratification relies on cytogenetic and molecular abnormalities defined by European LeukemiaNet (ELN) 2022. Conventional cytogenetic techniques, including chromosomal banding analysis (CBA) and fluorescence in situ hybridization, have limited resolution and may miss cryptic events. Optical genome mapping (OGM)
Audrey Bidet, Elodie Laharanne, Manon Dos Santos, Anne‐Charlotte De Grande, Thibaut Leguay, Arnaud Pigneux, Eric Frison, Sandrine Achard, Stéphanie Dupont‐Moufakkir, Emilie Klein, Pierre‐Yves Dumas   +10 more
wiley   +1 more source

Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivity. [PDF]

Exp Hematol Oncol
Hossain MF, Hagenau L, Jensen LR, Rhode J, Sura T, Salazar MG, Tzvetkova A, Jensen C, Edwards S, Dunkel H, Simm S, Radke J, Kuss AW.   +12 more
europepmc   +1 more source

Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance? [PDF]

Hematol Transfus Cell Ther
Omar MM, Alanazi MA, Jackson DE.
europepmc   +1 more source

Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-up. [PDF]

World J Urol
Pellegrino F, Grauer R, Falagario UG, Akre O, Aly M, Nordström T, Grönberg H, Egevad L, Tewari A, Ferro M, Gandaglia G, Briganti A, Montorsi F, Lantz A, Wiklund PN.   +14 more
europepmc   +1 more source

Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia

British Journal of Haematology, EarlyView.
Summary The modern management of chronic myeloid leukaemia (CML) identifies a new therapeutic goal of treatment‐free remission (TFR). Half of CML patients in durable deep molecular response (DMR) (MR4 or better) can remain off tyrosine kinase inhibitors (TKIs) without experiencing loss of major molecular response.
Simone Claudiani, Silvia Metelli, Afzal Khan, Guy Hannah, Jenny Byrne, Paolo Gallipoli, Simon J. Bulley, Gillian A. Horne, Kate Rothwell, Mhairi Copland, Richard E. Clark, Fiona Fernando, Andrew J. Innes, Jane F. Apperley, Dragana Milojkovic   +14 more
wiley   +1 more source